ETFs in Focus on Sanofi and Regeneron's COPD Drug Data
Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.
ETFs to Buy on UnitedHealth's Q2 Earnings Beat
UnitedHealth reported better-than-expected second-quarter 2022 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance for...
Simplify Announces Launch of the Simplify Macro Strategy ETF (FIG) Led by Hedge Fund Veteran Michael Green
Simplify Asset Management (“Simplify”) , an innovative provider of Exchange Traded Funds (“ETFs”) designed to solve today’s most pressing portfolio construction challenges, is today launching...
Healthcare ETFs to Gain on UnitedHealth's Solid Q1 Earnings
UnitedHealth reported better-than-expected first-quarter 2020 results, breezing past the Zacks Consensus Estimate for both earnings and revenues. The company lifted its full-year earnings guidance.